These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15976495)

  • 1. Tacrolimus and nonsteroidal anti-inflammatory drugs: an association to be avoided.
    Soubhia RM; Mendes GE; Mendonça FZ; Baptista MA; Cipullo JP; Burdmann EA
    Am J Nephrol; 2005; 25(4):327-34. PubMed ID: 15976495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of FK506 nephrotoxicity by sodium depletion in an experimental rat model.
    Andoh TF; Burdmann EA; Lindsley J; Houghton DC; Bennett WM
    Transplantation; 1994 Feb; 57(4):483-9. PubMed ID: 7509514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of the anti-inflammatory annexin A1 protein and tacrolimus immunosuppressant in the renal function of rats.
    Araujo LP; Truzzi RR; Mendes GE; Luz MA; Burdmann EA; Oliani SM
    Am J Nephrol; 2010; 31(6):527-33. PubMed ID: 20484890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction.
    Gislason GH; Jacobsen S; Rasmussen JN; Rasmussen S; Buch P; Friberg J; Schramm TK; Abildstrom SZ; Køber L; Madsen M; Torp-Pedersen C
    Circulation; 2006 Jun; 113(25):2906-13. PubMed ID: 16785336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension.
    Hermann M; Camici G; Fratton A; Hurlimann D; Tanner FC; Hellermann JP; Fiedler M; Thiery J; Neidhart M; Gay RE; Gay S; Lüscher TF; Ruschitzka F
    Circulation; 2003 Nov; 108(19):2308-11. PubMed ID: 14597594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse Drug Events Involving COX-2 Inhibitors.
    Verrico MM; Weber RJ; McKaveney TP; Ansani NT; Towers AL
    Ann Pharmacother; 2003 Sep; 37(9):1203-13. PubMed ID: 12921500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary enzymes as biomarkers of renal injury in experimental nephrotoxicity of immunosuppressive drugs.
    Burdmann EA; Andoh TF; Lindsley J; Russell J; Bennett WM; Porter G
    Ren Fail; 1994; 16(1):161-8. PubMed ID: 7514309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of rofecoxib on the glomerular filtration rate, proteinuria and the renin-angiotensin-aldosterone system in elderly subjects with chronic renal impairment.
    Horackova M; Schück O; Komers R; Charvat J; Teplan V; Kvapil M
    Int J Clin Pharmacol Ther; 2005 Sep; 43(9):413-9. PubMed ID: 16163893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
    Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
    Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis.
    Schneeweiss S; Solomon DH; Wang PS; Rassen J; Brookhart MA
    Arthritis Rheum; 2006 Nov; 54(11):3390-8. PubMed ID: 17075817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program.
    Weir MR; Sperling RS; Reicin A; Gertz BJ
    Am Heart J; 2003 Oct; 146(4):591-604. PubMed ID: 14564311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional and structural characteristics of experimental FK 506 nephrotoxicity.
    Andoh TF; Burdmann EA; Lindsley J; Houghton DC; Bennett WM
    Clin Exp Pharmacol Physiol; 1995 Sep; 22(9):646-54. PubMed ID: 8542679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory agents and renal function.
    Brater DC
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):33-42. PubMed ID: 12528072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracranial hypertension induced by rofecoxib.
    Jacob S; Rajabally YA
    Headache; 2005 Jan; 45(1):75-6. PubMed ID: 15663617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National trends in cyclooxygenase-2 inhibitor use since market release: nonselective diffusion of a selectively cost-effective innovation.
    Dai C; Stafford RS; Alexander GC
    Arch Intern Med; 2005 Jan; 165(2):171-7. PubMed ID: 15668363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [COX-2 inhibitors--one step forward and two steps back].
    Evensen S; Spigset O; Slørdal L
    Tidsskr Nor Laegeforen; 2005 Apr; 125(7):875-8. PubMed ID: 15815733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between aspirin and COX-2 inhibitors or NSAIDs in a rat thrombosis model.
    Umar A; Boisseau M; Yusup A; Upur H; Bégaud B; Moore N
    Fundam Clin Pharmacol; 2004 Oct; 18(5):559-63. PubMed ID: 15482377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrotoxicity of FK-506 in the rat. Studies on glomerular and tubular function, and on the relationship between efficacy and toxicity.
    Nielsen FT; Leyssac PP; Kemp E; Starklint H; Dieperink H
    Nephrol Dial Transplant; 1995; 10(3):334-40. PubMed ID: 7540737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib.
    Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A
    Ann Allergy Asthma Immunol; 2005 Jan; 94(1):34-8. PubMed ID: 15702813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the baseline cardiovascular risk profile among hypertensive patients prescribed COX-2-specific inhibitors or nonspecific NSAIDs: data from real-life practice.
    Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S392-400. PubMed ID: 12416789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.